Rosetta Capital Limited
rosettacapital.com Direct investor
Rosetta Capital Limited is a UK-based venture capital firm focused on the life sciences and medical device sectors. It invests through direct secondary transactions, providing liquidity solutions to investors and corporations, and manages a series of venture funds.
Rosetta Capital Limited is a venture capital firm headquartered in Oxford, United Kingdom. It invests directly in companies, in life sciences, medical device, therapeutics and diagnostics. 40 portfolio companies, as it reports.
“We invest in companies that have the potential to transform medical care. Our focus is on companies at late-preclinical or clinical stages of development that are developing innovative therapeutics, medical devices or diagnostics.”
— Rosetta Capital Limited, own website
- Layer
- Direct investor
- Type
- Venture capital
- Stage
- Not stated
- Headquarters
- Oxford, United Kingdom
- Invests in
- North America, Europe, Asia, global
- Portfolio
- 40 companies
Team, as Rosetta Capital Limited publishes it
- Jonathan Hepple Managing Partner
- Ken MacLeod Partner
- Michael Forer Partner
- Matthew James Chief Financial Officer
- Donovan Leung Investment Manager
Names and roles exactly as listed on rosettacapital.com. Nothing else about these people is recorded.
Where this comes from
Every fact above was read from a page Rosetta Capital Limited publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.
- http://www.rosettacapital.com/name, is_investor, layer, type, hq_country, hq_city, invests_in_geographies, sectors, description, status, confidence
- http://www.rosettacapital.com/our-people/thesis_quote, people
- http://www.rosettacapital.com/our-portfolio/portfolio_count
Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.
Record 10967 · added 2026-09-29 · link last verified 2026-09-29 · confidence high
Similar investors
- Monograph Capital Advisors (UK) LLPVenture capital · Seed – Series B · London, United Kingdom
- AbingworthVenture capital · Seed – Series C+ · London, United Kingdom
- Advent Life Sciences LLPVenture capital · Seed – Series B · London, United Kingdom
- Epidarex CapitalVenture capital · Seed – Series A · Edinburgh, United Kingdom
- Panacea Venture Management Company LTD.Venture capital · Seed – Growth · Grand Cayman, Singapore
- Calculus CapitalVenture capital · Seed – Growth · London, United Kingdom